HOME >> MEDICINE >> NEWS
Use of statins may prevent breast cancer, say University of Pittsburgh researchers

PITTSBURGH, Oct. 16 Cholesterol-lowering medications may help to prevent breast cancer in older women, according to study findings published by University of Pittsburgh researchers in the October issue of the Journal of Women's Health.

"While scientists have known for years that cholesterol inhibition serves to inhibit tumor cell growth, our analysis is one of the first to look exclusively at the relationship between lipid-lowering medications and the development of breast cancer, and our findings are dramatically positive," said study author and lead investigator Jane Cauley, Dr.P.H., professor of epidemiology at the University of Pittsburgh Graduate School of Public Health.

The Pittsburgh-led study found that older women who took statins and non-statin lipid-lowering drugs experienced a 60 to 70 percent reduction in their risk of breast cancer over approximately seven years.

Researchers reviewed data on 7,528 white women age 65 years and older who participated in the Study of Osteoporotic Fractures at sites in Pittsburgh, Baltimore, Minneapolis and Portland, and followed them for seven years.

A total of 234 (3.3%) cases of breast cancer were reported among the 6,952 participants who reported no use of lipid-lowering drugs; six cases (2.1%) among the 284 women who used statins; and four cases (1.3%) among the 292 who used nonstatin lipid-lowering drugs. The combined group of lipid-lowering drug users had a 68 percent reduction in the risk of breast cancer.

Investigators adjusted for body mass index and other risk factors for breast cancer such as the age at menarche, age at first birth, parity, physical activity and alcohol consumption. The results were essentially the same in all cases.

"There is a significant difference in the percentage of breast cancer events between women who used lipid-lowering drugs and those who did not, and these findings have important public health implications given the widespread use
'"/>

Contact: Kathryn Duda
DudaK@upmc.edu
412-624-2607
University of Pittsburgh Medical Center
16-Oct-2003


Page: 1 2

Related medicine news :

1. Hepatotoxicity and statins
2. Jefferson scientists help explain statins effects in Alzheimers disease
3. Jefferson scientists uncover new evidence to help explain statins effects in Alzheimers disease
4. CRESTOR leads in 1st international prospective study of statins in the metabolic syndrome
5. OTC statins: A bad decision for public health
6. ESC highlights need for screening and global risk management as statins move over the counter in UK
7. ACP guidelines: Many diabetics should be taking statins
8. Patients should be allowed to pay for statins
9. Genetic bar codes predict effect of statins
10. Stopping statins may cause rebound that triples risk of death
11. Not enough evidence that multivitamins prevent infections in the elderly

Post Your Comments:
(Date:5/20/2013)... York (PRWEB) May 20, 2013 ... forward in the multidistrict litigation recently established in U.S. ... LLP reports. According to court records, the litigation’s ... which time appointments to Plaintiff’s leadership positions were discussed. ... pending in the Southern District of New York, all ...
(Date:5/20/2013)... According to a June 2009 Bloomberg article, ... amount to approximately $3.6 billion dollars per year (i). ... estimated that there 15 million incidents of medical harm ... everyone who receives any form of medical treatment should ... Merriam-Webster defines malpractice as “a dereliction of professional duty ...
(Date:5/20/2013)... MO (PRWEB) May 20, 2013 yurbuds®, ... or fall out, today announced the launch of its ... and Signature Series-Pete Jacobs, with more signature athletes to ... in mind, Signature Series ITE 100 is the perfect ... Signature Series ITE 100 features reflective, tangle-resistant Kevlar cords, ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 The ... business and community leaders behind bars for good at ... May 22 beginning at 9 a.m. , More ... annual Executive Lock-Up to benefit individuals and families affected ... present, including city officials, local celebrities, realtors, doctors, attorneys, ...
(Date:5/20/2013)... May 2013 While Huntington,s disease (HD) is ... new disease-modifying therapies in development may slow or ... research depends upon the identification of reliable and ... and these biomarkers may eventually be used as ... especially helpful to monitor changes during the time ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- It is no secret that Americans have ... or obese gyms and supplement companies are in line to ... primarily related to dietary issues and a lack of physical ... a glandular problem or even a vitamin deficiency. ... is a lack of vitamin b12 . The vitamin ...
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... lecturer Dr. Christine Ginocchio ... upcoming solution for rapid identification of microorganisms producing ... Director and Chief of the Division of Infectious ... nation,s 2nd largest not-for-profit, non-sectarian health system. ...
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11
Cached News: